A strategy to improve the solubility and bioavailability of the insoluble drug piperlongumine through albumin nanoparticles.

Niu, Sen; Li, Xurui; Guo, Zhongqiu; Wan, David; Liu, Yu; Li, Li; Dong, Meng; Jia, Xirong.

Afiliación

Niu S; Department of Pharmaceutical Engineering, Xuzhou Pharmaceutical Higher Vocational School of Jiangsu Province, Xuzhou, China.
Li X; School of Pharmaceutical Sciences, Liaoning University, Shenyang, Liaoning, China.
Guo Z; School of Pharmaceutical Sciences, Liaoning University, Shenyang, Liaoning, China.
Wan D; Beijing Rule Biopharma, Co., Ltd., Beijing, China.
Liu Y; School of Pharmaceutical Sciences, Liaoning University, Shenyang, Liaoning, China.
Li L; School of Pharmaceutical Sciences, Liaoning University, Shenyang, Liaoning, China.
Dong M; School of Pharmaceutical Sciences, Liaoning University, Shenyang, Liaoning, China.
Jia X; School of Pharmaceutical Sciences, Liaoning University, Shenyang, Liaoning, China.

Pak J Pharm Sci ; 36(2): 483-490, 2023 Mar.

Article en En | MEDLINE | ID: mdl-37530156

Asunto(s)

Antineoplásicos; Nanopartículas; Solubilidad; Albúmina Sérica Bovina; Disponibilidad Biológica; Preparaciones de Acción Retardada; Antineoplásicos/farmacología; Tamaño de la Partícula; Portadores de Fármacos/farmacocinética; Línea Celular Tumoral

Buscar en Google